title: Drug resistance patterns among hospitalized tuberculous patients in Rio de Janeiro, Brazil, 1993-1994.
abstract: The purpose of this study was to analyze the prevalence and risk factors for drug resistance among hospitalized patients in two tertiary care centers, an acquired immunodeficiency syndrome (AIDS) reference center and a sanatorium, in Rio de Janeiro, Brazil. From 1993-1994, 389 patients were diagnosed as having tuberculosis (TB). Isolates from 265 patients were tested for in vitro susceptibility to rifampin and isoniazid. Resistance to one or more drugs was detected in 44 patients (16.6%) and was significantly more common among recurrent cases in both hospitals (p=0.03 in the AIDS center and p=0.001 in the sanatorium). Twenty seven patients (10.2%) had isolates resistant to both isoniazid and rifampin. Multi-drug resistance was associated with human immunodeficiency virus (HIV) infection among patients who had never been treated for TB. In conclusion, drug-resistant TB is high in hospitalized patients in Rio de Janeiro, especially among HIV infected patients. Therefore, measures to control TB and prevent nosocomial transmission need urgently to be set up in the Brazilian hospitals.
authors.affiliation: Departamento de Desenvolvimento Tecnológico e Produtos Imunobiológicos, Fiocruz, Rio de Janeiro, RJ, Brasil.
authors.forename: F
authors.initials: F
authors.lastname: Fandinho
authors.forename: A
authors.initials: A
authors.lastname: Kritski
authors.forename: C
authors.initials: C
authors.lastname: Hofer
authors.forename: H
authors.initials: H
authors.lastname: Conde
authors.forename: R
authors.initials: R
authors.lastname: Ferreira
authors.forename: M
authors.initials: M
authors.lastname: Silva
authors.forename: L
authors.initials: L
authors.lastname: Fonseca
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D000293:Adolescent; D000328:Adult; D000995:Antitubercular Agents / Q000494:pharmacology*; D001938:Brazil; D004198:Disease Susceptibility; D004352:Drug Resistance, Microbial; D005260:Female; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D015995:Prevalence; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin